Illumina Sues Premaitha Health Over Patents

San Diego-based life sciences equipment developer Illumina says it has filed a new patent infringement suit against Premaitha Health plc, in the United Kingdom. According to Illumina, its new suit accuses Premaitha of infringing upon European Patent (UK) 1 524 321 B2 titled, "Non-invasive Detection of Fetal Genetic Traits". Illumina said that the patent in question is exclusively licensed to Illumina from Sequenom. Illumina has a number of lawsuits filed against Premaitha, accusing the firm of infringing upon a number of its other European patents.